B regulatory cells are numerically but not functionally impaired in AAV
S.K. Todd(The Royal Free Hospital), Alan D. Salama(The Royal Free Hospital), Anisha Tanna(Hammersmith Hospital), Claudia Mauri(The Royal Free Hospital), Ruth J. Pepper(University College Hospital)
Cited by 1
Related Papers
Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids
|Annals of the Rheumatic Diseases|2013|454
Aryl Hydrocarbon Receptor Contributes to the Transcriptional Program of IL-10-Producing Regulatory B Cells
|Cell Reports|2019|176
Rituximab is an effective treatment for lupus nephritis and allows a reduction in maintenance steroids
|Nephrology Dialysis Transplantation|2009|156
Rituximab is effective in the treatment of refractory Churg-Strauss syndrome and is associated with diminished T-cell interleukin-5 production
|Lara D. Veeken|2008|149
Suppression of TNF-alpha expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipram
|The Journal of Immunology|1997|113